2-Chlorobenzimidazole → (1H-Benzoimidazol-2-yl)indan-1-ylamine

HRID 16546

Reaktionsgleichung

Reaktionsgleichung von HRID 16546
Cl[C:2]1[NH:3][C:4]2[CH:10]=[CH:9][CH:8]=[CH:7][C:5]=2[N:6]=1.[NH2:11][CH:12]1[C:20]2[C:15](=[CH:16][CH:17]=[CH:18][CH:19]=2)[CH2:14][CH2:13]1>>[N:6]1[C:5]2[CH:7]=[CH:8][CH:9]=[CH:10][C:4]=2[NH:3][C:2]=1[NH:11][CH:12]1[C:20]2[C:15](=[CH:16][CH:17]=[CH:18][CH:19]=2)[CH2:14][CH2:13]1

Komponenten

3

Versuchsvorschrift

The title compound was prepared from 2-chlorobenzimidazole and racemic 1-aminoindane by Procedure A (15 min at 200° C.). The product was isolated by preparative LCMS to give the title compound as the free base and as a mixture of enantiomers (white solid, mp 195.5-197° C.). MS(ES+) m/z 250 ([M+1]+, 100). 1NMR (DMSO-d6) δ 1.90 (m, 1 H), 2.55 (m, 1 H), 2.83 (m, 1 H), 2.95 (m, 1 H), 5.36 (m, 1 H), 6.82-6.97 (m, 3H), 7.11-7.31 (m, 6H), 10.70 (s, 1H).

Aufarbeitung

  1. customThe product was isolated by preparative LCMS

Quellen und Nachweise

ORD-Eintrag
ord-0286d6bc0d514964b3e0f0f87c14b814
Quelldatensatz
uspto-grants-2010_06
Patentnummer
US07737167B2

Verknüpfte Notizen

Wird geladen…